# Biodesix, Inc. (BDSX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BDSX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 52.42M | $ -15.07M | $ -12.13M | $ 71.80M | $ 9.14M |
| 2025 | $ 90.62M | $ -36.11M | $ -24.24M | $ 72.85M | $ -2.47M |
| 2024 | $ 74.97M | $ -45.12M | $ -54.77M | $ 61.98M | $ 20.88M |
| 2023 | $ 53.08M | $ -56.38M | $ -49.66M | $ 60.69M | $ 4.58M |
| 2022 | $ 42.69M | $ -73.11M | $ -54.19M | $ 31.85M | $ 20.61M |
| 2021 | $ 64.79M | $ -51.30M | $ -36.57M | $ 10.01M | $ 19.73M |
| 2020 | $ 58.04M | $ -39.94M | $ -23.41M | $ 27.77M | $ 41.17M |
| 2019 | $ 31.69M | $ -39.66M | $ -29.75M | $ 35.97M | $ -225.14M |
| 2018 | $ 13.49M | $ -17.28M | $ -12.08M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 7.85 |
| Liabilities / Eq | 9.42 |
| Current Ratio | 2.85 |

## Other views

- [Metrics](https://sponda.capital/en/BDSX.md)
- [Charts](https://sponda.capital/en/BDSX/charts.md)
- [Compare](https://sponda.capital/en/BDSX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.